Safety and efficacy of Myobloc® (botulinum toxin type B) for sialorrhea in Parkinson's disease (PD) patients

被引：0
作者：
Pappert, Eric [1 ]
Reinhard, Sharon [1 ]
Salazar-Grueso, Edgar [1 ]
机构：
[1] Solstice Neurosci Inc, Malvern, PA USA
来源：
TOXICON | 2008年 / 51卷
关键词：
botulinum toxin B; sialorrhea;
D O I：
10.1016/j.toxicon.2008.04.154
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
152
引用
收藏
页码：51 / 51
页数：1
相关论文
共 46 条
  • [31] The option of sonographic guidance in Botulinum toxin injection for drooling in Parkinson's disease
    Jost, Wolfgang H.
    JOURNAL OF NEURAL TRANSMISSION, 2016, 123 (01) : 51 - 55
  • [32] Saliva changes in Parkinson’s disease patients after injection of Botulinum neurotoxin type A
    Janne Tiigimäe-Saar
    Tiia Tamme
    Marika Rosenthal
    Liis Kadastik-Eerme
    Pille Taba
    Neurological Sciences, 2018, 39 : 871 - 877
  • [33] Saliva changes in Parkinson's disease patients after injection of Botulinum neurotoxin type A
    Tiigimae-Saar, Janne
    Tamme, Tiia
    Rosenthal, Marika
    Kadastik-Eerme, Liis
    Taba, Pille
    NEUROLOGICAL SCIENCES, 2018, 39 (05) : 871 - 877
  • [34] Effect of obstructive sleep apnea risk on sialorrhea in patients with Parkinson's disease
    Ozkutlu, Ozge
    Demir, Esma
    Unluer, Nezehat Ozgul
    Sonkaya, Riza
    SLEEP AND BREATHING, 2025, 29 (01)
  • [35] Efficacy of Botulinum Toxin B Injection for Raynaud's Phenomenon and Digital Ulcers in Patients with Systemic Sclerosis
    Motegi, Sei-ichiro
    Uehara, Akihito
    Yamada, Kazuya
    Sekiguchi, Akiko
    Fujiwara, Chisako
    Toki, Sayaka
    Date, Yuki
    Nakamura, Tetsuya
    Ishikawa, Osamu
    ACTA DERMATO-VENEREOLOGICA, 2017, 97 (07) : 843 - 850
  • [36] Deep brain stimulation of the subthalamic nucleus increases the risk of sialorrhea in patients with advanced Parkinson's disease
    Sun, Jinxing
    Cheng, Lian
    Li, Zhenke
    Jia, Junheng
    Wu, Qianqian
    Hou, Ying
    Wang, Qi
    Zhang, Guangjian
    Wang, Hong
    Li, Xingang
    Li, Weiguo
    Zhang, Chao
    PARKINSONISM & RELATED DISORDERS, 2024, 123
  • [37] EFFICACY OF INCOBOTULINUMTOXINA IN SUBJECTS WITH SIALORRHEA, ASSESSED USING THE MODIFIED RADBOUD ORAL MOTOR INVENTORY FOR PARKINSON'S DISEASE (MROMP)
    Jost, Wolfgang H.
    Michel, Olaf
    Oehlwein, Christian
    Slawek, Jaroslaw
    Bogucki, Andrzej
    Ochudlo, Stanislaw
    Banach, Marta
    Pagan, Fernando
    Flatau-Baque, Birgit
    Csikos, Janos
    Blitzer, Andrew
    TOXICON, 2018, 156 : S53 - S54
  • [38] Effectiveness of the pharmacological treatments for sialorrhea in patients with Parkinson’s disease: a systematic review and network meta-analysis
    Luiz Carlos Santos Junior
    José Ronaldo Santos
    Alessandra Reis
    André Luís Faria-e-Silva
    Pollyana Caldeira Leal
    Clinical Oral Investigations, 2023, 27 : 2449 - 2463
  • [39] Drooling in Parkinson's disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins
    Narayanaswami, Pushpa
    Geisbush, Thomas
    Tarulli, Andrew
    Raynor, Elizabeth
    Gautam, Shiva
    Tarsy, Daniel
    Gronseth, Gary
    PARKINSONISM & RELATED DISORDERS, 2016, 30 : 73 - 77
  • [40] Effectiveness of the pharmacological treatments for sialorrhea in patients with Parkinson's disease: a systematic review and network meta-analysis
    Santos Jr, Luiz Carlos
    Santos, Jose Ronaldo
    Reis, Alessandra
    Faria-e-Silva, Andre Luis
    Leal, Pollyana Caldeira
    CLINICAL ORAL INVESTIGATIONS, 2023, 27 (06) : 2449 - 2463
12345